Ingrid Kane
Chief Tech/Sci/R&D Officer at SIGHT SCIENCES, INC.
Ingrid Kane active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SIGHT SCIENCES, INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Ingrid Kane
Former positions of Ingrid Kane
| Companies | Position | Start | End |
|---|---|---|---|
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Ingrid Kane
| University of Charles | Doctorate Degree |
Statistics
International
| United States | 3 |
| Czech Republic | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Health Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SIGHT SCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
- Stock Market
- Insiders
- Ingrid Kane
- Experience
